Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Opioid Withdrawal”

Showing 20 of 0 results

Not applicableLooking for participantsNCT06487533
What this trial is testing

Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

Who this might be right for
Opioid WithdrawalOpioid Use Disorder
Spark Biomedical, Inc. 20
Large-scale testing (Phase 3)Study completedNCT02946073
What this trial is testing

Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain

Who this might be right for
Chronic Lower Back PainChronic Pain
Braeburn Pharmaceuticals 1,053
Post-approval studies (Phase 4)Study completedNCT01702389
What this trial is testing

Opioid-induced Hyperalgesia After Remifentanil Infusion

Who this might be right for
Hyperalgesia
Oslo University Hospital 16
Not applicableLooking for participantsNCT07079215
What this trial is testing

Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms

Who this might be right for
Opioid Withdrawal (Disorder)Opioid Use Disorder
Nu Eyne Co., Ltd. 24
Post-approval studies (Phase 4)UnknownNCT03397212
What this trial is testing

Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients

Who this might be right for
Chronic PainOpiate Withdrawal Syndrome
Rigshospitalet, Denmark 50
Testing effectiveness (Phase 2)UnknownNCT04234191
What this trial is testing

Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Who this might be right for
Opioid Use Disorder
University of British Columbia 50
Large-scale testing (Phase 3)Study completedNCT02391571
What this trial is testing

Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects

Who this might be right for
Withdrawal Symptoms
Elite Laboratories, Inc 26
Large-scale testing (Phase 3)UnknownNCT04808531
What this trial is testing

NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers

Who this might be right for
Cancer Related Pain
Medlab Clinical 360
Testing effectiveness (Phase 2)Study completedNCT00000244
What this trial is testing

Effects of Dynorphin 1-13 on Heroin Addiction - 1

Who this might be right for
Opioid-Related DisordersSubstance Withdrawal Syndrome
University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT02548728
What this trial is testing

Oxytocin Treatment of Opioid Dependence

Who this might be right for
Opioid DependenceOpioid Withdrawal
University of North Carolina, Chapel Hill 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05712707
What this trial is testing

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Who this might be right for
Opioid Use DisorderOpioid Withdrawal
New York State Psychiatric Institute 160
Not applicableStudy completedNCT00661674
What this trial is testing

Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal

Who this might be right for
Substance-Related Disorders
Stanford University 10
Post-approval studies (Phase 4)Study completedNCT04298853
What this trial is testing

Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

Who this might be right for
Neonatal Abstinence SyndromeNeonatal Opioid WithdrawalNeonatal Opioid Withdrawal Syndrome
Indiana University 17
Not applicableEnded earlyNCT05924945
What this trial is testing

Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms

Who this might be right for
Opioid Use Disorder
Masimo Corporation 13
Large-scale testing (Phase 3)Study completedNCT02810782
What this trial is testing

How to Treat Opiate Withdrawal in Neonates

Who this might be right for
Neonatal Abstinence Syndrome
University of Zurich 120
Testing effectiveness (Phase 2)UnknownNCT03156907
What this trial is testing

High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid

Who this might be right for
High Dosage Buprenorphine
University Hospital, Clermont-Ferrand 60
Testing effectiveness (Phase 2)Looking for participantsNCT05995535
What this trial is testing

Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal

Who this might be right for
Opiate Withdrawal SyndromeOpioid Use
University of Pennsylvania 150
Not applicableStudy completedNCT03987165
What this trial is testing

The Effect of Music Therapy on Newborns

Who this might be right for
Neonatal Abstinence SyndromeSubstance Withdrawal, Neonatal
Tulane University 42
Not applicableStudy completedNCT03756233
What this trial is testing

Gradual Withdrawal of Remifentanil Infusion Reduced Postoperative Pain and Opioid Requirement During Breast Surgery

Who this might be right for
Pain, Postoperative
Samsung Medical Center 60
Early research (Phase 1)Study completedNCT00521248
What this trial is testing

Buprenorphine for the Treatment of Neonatal Abstinence Syndrome

Who this might be right for
Neonatal Abstinence Syndrome
Thomas Jefferson University 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation